Reproductive health
NGS-based preimplantation genetic testing (PGT) facilitates the identification of embryos with euploidy, aneuploidy, and chromosomal mosaicism, thus improving IVF pregnancy outcomes compared with array CGH-based screening.
We have utilized our PicoPLEX whole genome amplification technology along with our patented library prep technology in the Embgenix PGT-A Kit for TE biopsy samples and Embgenix ESM Screen Kit for noninvasive samples. The simple protocols for these kits dramatically improve time to results while reducing handling errors and background. In addition to complete whole genome amplification and library prep, these kits also include proprietary, cloud-based analysis software for accurate detection of aneuploidy and copy number variation, with easy reporting.
Click the boxes below for the research-use version of the Embgenix PGT-A Kit or the Embgenix ESM Screen Kit.
Interested in a CE-marked version of the Embgenix PGT-A Kit? Visit the Embgenix PGT-A Kit (CE-IVD) product page.
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2022 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.
